Bill number does not exist. Enter a vaild keyword.

Committee Testimony and Witness Signup

SB0200 - Public Health - Prescription Drug Monitoring Program - Naloxone Medication Data

Finance 1/27/2022 2:00:00 PM
Health and Government Operations 3/30/2022 1:30:00 PM
As of: 10/1/2022 11:18:50 AM
Name Organization Position Testimony Committee
Chair, Finance Committee, Chair, Finance Committee FAV Oral Testimony FIN
Gribble, Anna Maryland Department of Health FAV Oral Testimony FIN
Rosen-Cohen, Nancy NCADD-Maryland FAV NCADD-MD - SB 200 FAV - Naloxone PDMP.pdf FIN
Shek, Heather Maryland Department of Health FAV Oral Testimony
2 - SB 200 - FIN - MDH - LOS.pdf
FIN
Doherty, Daniel FAV No Testimony FIN
Kasemeyer, Pam FAV SB0200_FAV_MedChi, MDACEP_PDMP - Naloxone Medicati FIN
Testimony, All N/A Merged Testimony as of 1-25-2022 at 306 PM FIN
Chair, Finance Committee, Chair, Finance Committee FAV Oral Testimony HGO
Rosen-Cohen, Nancy NCADD-Maryland FAV NCADD-MD - SB 200 FAV - Naloxone PDMP - House.pdf HGO
Gribble, Anna Maryland Department of Health FAV Oral Testimony HGO
Kasemeyer, Pam FAV SB0200 - House_FAV_MedChi, MDACEP_PDMP - Naloxone HGO
Shek, Heather Maryland Department of Health FAV 8 - X - SB 200 - HGO - MDH - LOSAA.docx.pdf HGO
Duffy, Suzanne Concerned Citizen UNF No Testimony HGO
Click to return on the top page